Sweden believes in EMA candidacy despite criticism

The European Medicines Agency (EMA) is highly critical of the Swedish bid to house the agency when it leaves London. The rejection is based on an evaluation of the buildings in Stockholm planned to be the new headquarters of EMA. The Swedish EMA-ambassador calls the critique “misleading”.

Photo: PR-visualisering

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Omstridt parallelimportør går konkurs

Parallelimportøren Europharma, der to gange i 2017 blev suspenderet af Lægemiddelstyrelsen, er gået konkurs. Selskabet har erkendt, at et varelager for 50 mio. kr. er usælgeligt.

Related articles